Juno Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch JUNO and buy or sell other stocks, ETFs, and their options commission-free!About JUNO
Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors.
CEOHans E. Bishop
CEOHans E. Bishop
Employees—
Employees—
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2013
Founded2013
Employees—
Employees—
JUNO Key Statistics
Market cap9.94B
Market cap9.94B
Price-Earnings ratio-21.42
Price-Earnings ratio-21.42
Dividend yield—
Dividend yield—
Average volume2.81M
Average volume2.81M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$87.01
52 Week high$87.01
52 Week low$19.62
52 Week low$19.62
Stock Snapshot
As of today, Juno Therapeutics(JUNO) shares are valued at $86.96. The company's market cap stands at 9.94B, with a P/E ratio of -21.42.
Juno Therapeutics(JUNO) stock opened on 2025-12-11 at —. The price climbed to — and dipped to —.
Juno Therapeutics(JUNO) shares are trading with a volume of 0, against a daily average of 2.81M.
During the past year, Juno Therapeutics(JUNO) stock moved between $19.62 at its lowest and $87.01 at its peak.
During the past year, Juno Therapeutics(JUNO) stock moved between $19.62 at its lowest and $87.01 at its peak.